This company will be out of cash by Feb. They will need to do a financing in next month or so, and given the runup this would be a great time to do it. Longs should be aware that financing would bring the stock price down though.
You don't know what you are talking about. They haven't even filed an NDA so no FDA approval possible for 8 - 14 months at best. Partners want to see a drug that has had at least an NDA submitted. Forget what the company says, if you calculate their burn rate and runway it get them into Feb.